Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Mind Medicine Inc (NASDAQ: MNMD) was $11.34 for the day, down -1.65% from the previous closing price of $11.53. In other words, the price has decreased by -$1.65 from its previous closing price. On the day, 1.47 million shares were traded. MNMD stock price reached its highest trading level at $11.7 during the session, while it also had its lowest trading level at $11.13.
Ratios:
Our analysis of MNMD’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Needham on October 13, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.Evercore ISI initiated its Outperform rating on January 28, 2025, with a $23 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 25 ’25 when Sullivan Mark sold 11,278 shares for $9.77 per share. The transaction valued at 110,186 led to the insider holds 293,852 shares of the business.
Barrow Robert sold 25,797 shares of MNMD for $252,037 on Sep 25 ’25. The Chief Executive Officer now owns 804,268 shares after completing the transaction at $9.77 per share. On Sep 25 ’25, another insider, Karlin Daniel, who serves as the Chief Medical Officer of the company, sold 7,704 shares for $9.77 each. As a result, the insider received 75,268 and left with 430,625 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 1102465664 and an Enterprise Value of 721035264.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.82, which has changed by 0.35806835 over the last 52 weeks, in comparison to a change of 0.13355756 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $14.43, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 0.93%, while the 200-Day Moving Average is calculated to be 34.98%.
Shares Statistics:
MNMD traded an average of 1.71M shares per day over the past three months and 2502210 shares per day over the past ten days. A total of 75.80M shares are outstanding, with a floating share count of 72.58M. Insiders hold about 3.94% of the company’s shares, while institutions hold 54.35% stake in the company. Shares short for MNMD as of 1760486400 were 10063593 with a Short Ratio of 5.90, compared to 1757894400 on 10692593. Therefore, it implies a Short% of Shares Outstanding of 10063593 and a Short% of Float of 13.33.
Earnings Estimates
The performance of Mind Medicine Inc (MNMD) in the stock market is under the watchful eye of 8.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.43 and low estimates of -$0.56.
Analysts are recommending an EPS of between -$1.61 and -$1.9 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.83, with 9.0 analysts recommending between -$1.0 and -$2.22.
